OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease
Santica M. Marcovina
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 560-572
Closed Access | Times Cited: 8
Santica M. Marcovina
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 560-572
Closed Access | Times Cited: 8
Showing 8 citing articles:
The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease
Qianhui Li, Shuailei Xu, Junxian Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Qianhui Li, Shuailei Xu, Junxian Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lipoprotein(a) levels and cardiovascular mortality risk in Chinese patients undergoing hemodialysis
Qiaojing Liang, Guojuan Zhang, Liping Jiang, et al.
International Urology and Nephrology (2025)
Closed Access
Qiaojing Liang, Guojuan Zhang, Liping Jiang, et al.
International Urology and Nephrology (2025)
Closed Access
The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study
Lijun Qiu, Hongwei Qiao
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Lijun Qiu, Hongwei Qiao
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Elevated Lipoprotein(a)-Associated Coronary Artery Disease in a 45-Year-Old Male
Fatima Abeer, Adil Wani, Ali Ahraz
Cureus (2025)
Open Access
Fatima Abeer, Adil Wani, Ali Ahraz
Cureus (2025)
Open Access
Potential of muvalaplin as a lipoprotein(a) inhibitor
Amanda J. Hooper, P. Mihika S. Fernando, John R. Burnett
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 1, pp. 5-7
Open Access | Times Cited: 4
Amanda J. Hooper, P. Mihika S. Fernando, John R. Burnett
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 1, pp. 5-7
Open Access | Times Cited: 4
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease
P. Mihika S. Fernando, Amanda J. Hooper, John R. Burnett
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 657-659
Open Access | Times Cited: 1
P. Mihika S. Fernando, Amanda J. Hooper, John R. Burnett
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 657-659
Open Access | Times Cited: 1
Association between lipoprotein (a) and risk of atherosclerotic cardiovascular disease events among maintenance hemodialysis patients in Beijing, China: a single-center, retrospective study
Qiaojing Liang, Guojuan Zhang, Liping Jiang
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Qiaojing Liang, Guojuan Zhang, Liping Jiang
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Prediction of atherosclerotic cardiovascular risk in early childhood
Simona Ferraro, Sara Benedetti, Savina Mannarino, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117684-117684
Closed Access | Times Cited: 2
Simona Ferraro, Sara Benedetti, Savina Mannarino, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117684-117684
Closed Access | Times Cited: 2
